Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Atar

Showing results (281-290 of 405) with videos related to

Pageof 41
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 22, 2023
Glycaemic control and insulin therapy are significant confounders of the obesity paradox in patients with heart failure and diabetes mellitusHanna Fröhlich, Anna Bossmeyer, Syed Kazmi, et al.
Journal of the American Heart Association|March 11, 2016
Sample Size in Clinical Cardioprotection Trials Using Myocardial Salvage Index, Infarct Size, or Biochemical Markers as EndpointHenrik Engblom, Einar Heiberg, David Erlinge, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 11, 2026
Secondary prevention with beta-blockers after myocardial infarctionJohn Munkhaugen, Arnhild Bakken, Anna Meta Dyrvig Kristiansen, et al.
Public Health in Practice (Oxford, England)|February 3, 2025
Development and psychometric validation of the frontline health workers' occupational risk and characteristics in emergencies index (FORCE-index) - The covid Hospital cohort studySynne Øien Stensland, Kristina Bondjers, John-Anker Zwart, et al.
Circulation Research|October 14, 2006
Time course of degradation of cardiac troponin I in patients with acute ST-elevation myocardial infarction: the ASSENT-2 troponin substudyLene H Madsen, Geir Christensen, Terje Lund, et al.
The American Journal of Medicine|November 11, 2017
Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE TrialMeena P Rao, Dragos Vinereanu, Daniel M Wojdyla, et al.
Journal of the American Heart Association|June 23, 2026
Dynamic Risk Trajectories for Sudden Cardiac Arrest: The Role of Recurrent Cardiovascular EventsMarita Knudsen Pope, Harpriya Chugh, Thien Tan Tri Tai Truyen, et al.
Stroke|November 2, 2017
Echocardiographic Risk Factors for Stroke and Outcomes in Patients With Atrial Fibrillation Anticoagulated With Apixaban or WarfarinDragos Vinereanu, Renato D Lopes, Hillary Mulder, et al.
Medrxiv : the Preprint Server for Health Sciences|November 26, 2025
Dynamic Risk Trajectories for Sudden Cardiac Arrest: The Role of Recurrent Cardiovascular EventsMarita Knudsen Pope, Harpriya Chugh, Thien Tan Tri Tai Truyen, et al.
Heart (British Cardiac Society)|February 23, 2019
Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern EuropeHanna Fröhlich, Niklas Rosenfeld, Tobias Täger, et al.
Pageof 41

Showing results (281-290 of 405) with videos related to

Sort By:
Pageof 41
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 22, 2023
Glycaemic control and insulin therapy are significant confounders of the obesity paradox in patients with heart failure and diabetes mellitusHanna Fröhlich, Anna Bossmeyer, Syed Kazmi, et al.
Journal of the American Heart Association|March 11, 2016
Sample Size in Clinical Cardioprotection Trials Using Myocardial Salvage Index, Infarct Size, or Biochemical Markers as EndpointHenrik Engblom, Einar Heiberg, David Erlinge, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 11, 2026
Secondary prevention with beta-blockers after myocardial infarctionJohn Munkhaugen, Arnhild Bakken, Anna Meta Dyrvig Kristiansen, et al.
Public Health in Practice (Oxford, England)|February 3, 2025
Development and psychometric validation of the frontline health workers' occupational risk and characteristics in emergencies index (FORCE-index) - The covid Hospital cohort studySynne Øien Stensland, Kristina Bondjers, John-Anker Zwart, et al.
Circulation Research|October 14, 2006
Time course of degradation of cardiac troponin I in patients with acute ST-elevation myocardial infarction: the ASSENT-2 troponin substudyLene H Madsen, Geir Christensen, Terje Lund, et al.
The American Journal of Medicine|November 11, 2017
Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE TrialMeena P Rao, Dragos Vinereanu, Daniel M Wojdyla, et al.
Journal of the American Heart Association|June 23, 2026
Dynamic Risk Trajectories for Sudden Cardiac Arrest: The Role of Recurrent Cardiovascular EventsMarita Knudsen Pope, Harpriya Chugh, Thien Tan Tri Tai Truyen, et al.
Stroke|November 2, 2017
Echocardiographic Risk Factors for Stroke and Outcomes in Patients With Atrial Fibrillation Anticoagulated With Apixaban or WarfarinDragos Vinereanu, Renato D Lopes, Hillary Mulder, et al.
Medrxiv : the Preprint Server for Health Sciences|November 26, 2025
Dynamic Risk Trajectories for Sudden Cardiac Arrest: The Role of Recurrent Cardiovascular EventsMarita Knudsen Pope, Harpriya Chugh, Thien Tan Tri Tai Truyen, et al.
Heart (British Cardiac Society)|February 23, 2019
Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern EuropeHanna Fröhlich, Niklas Rosenfeld, Tobias Täger, et al.
Pageof 41